| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.248 | 29.677 | 21.985 | 28.131 | 34.479 | 31.712 | 35.964 | 33.481 | 32.678 |
| Total Income - EUR | - | 1.248 | 29.677 | 22.952 | 35.243 | 34.479 | 31.712 | 35.964 | 33.481 | 32.678 |
| Total Expenses - EUR | - | 2.154 | 33.416 | 25.999 | 29.787 | 32.773 | 30.185 | 32.912 | 30.565 | 24.504 |
| Gross Profit/Loss - EUR | - | -906 | -3.739 | -3.047 | 5.455 | 1.705 | 1.527 | 3.052 | 2.916 | 8.174 |
| Net Profit/Loss - EUR | - | -943 | -4.093 | -3.268 | 5.228 | 1.374 | 1.205 | 2.698 | 2.465 | 7.063 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Maraştef Sanofarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 2.078 | 1.715 | 1.361 | 1.019 | 689 | 371 | 68 | 68 | 1.900 |
| Current Assets | - | 5.739 | 15.422 | 5.418 | 9.458 | 11.651 | 12.620 | 5.436 | 7.129 | 11.481 |
| Inventories | - | 4.539 | 1.337 | 4.079 | 1.604 | 1.865 | 2.098 | 1.793 | 1.906 | 2.985 |
| Receivables | - | 0 | 9 | 981 | 751 | 14 | 13 | 13 | 13 | 13 |
| Cash | - | 1.200 | 14.076 | 358 | 7.102 | 9.772 | 10.509 | 3.630 | 5.210 | 8.482 |
| Shareholders Funds | - | -899 | -4.976 | -8.153 | -2.768 | -1.341 | -106 | 2.592 | 5.048 | 12.083 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 8.716 | 22.113 | 14.932 | 13.245 | 13.681 | 13.097 | 2.912 | 2.148 | 1.297 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4729 - 4729" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Maraştef Sanofarm Srl